FDA.reportPublic FDA data

berotralstat 132 MG Oral Pellet

RxCUI
2728880
RxNorm name
berotralstat 132 MG Oral Pellet
Display name
berotralstat 132 MG Oral Pellet
Full name
berotralstat 132 MG Oral Pellet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OrladeyoBEROTRALSTAT HYDROCHLORIDEBioCryst Pharmaceuticals, Inc.3527ece1-e7e0-40b1-b0c5-6baeb0deabeb2026-02-13Warnings, Adverse reactionsExact identifier
rxcui: 2728880

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3527ece1-e7e0-40b1-b0c5-6baeb0deabebberotralstat 132 MG Oral PelletPSN8These highlights do not include all the information needed to use ORLADEYO ® safely and effectively. See full prescribing information for ORLADEYO. ORLADEYO (berotralstat) capsules, for oral use ORLADEYO (berotralstat) oral pellets Initial U.S. Approval: 202020260213
3527ece1-e7e0-40b1-b0c5-6baeb0deabebberotralstat 132 MG Oral PelletSCD8These highlights do not include all the information needed to use ORLADEYO ® safely and effectively. See full prescribing information for ORLADEYO. ORLADEYO (berotralstat) capsules, for oral use ORLADEYO (berotralstat) oral pellets Initial U.S. Approval: 202020260213